Alignment Healthcare (ALHC) insider General Atlantic unloads 11.1M shares
Rhea-AI Filing Summary
General Atlantic (ALN HLTH), L.P., a 10% owner of Alignment Healthcare, Inc., reported an open market sale of 11,119,494 shares of common stock at $18.57 per share, settled on December 12, 2025.
After this transaction, it beneficially owned 13,476,585 shares of Alignment Healthcare common stock indirectly, with the structure involving multiple General Atlantic investment funds and shares and restricted stock units held by Nicholas Robbert Vorhoff and David C. Hodgson for the benefit of General Atlantic Service Company, L.P.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.001 per share | 11,119,494 | $18.57 | $206.49M |
Footnotes (1)
- The shares of Common Stock were sold by General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), pursuant to an open market sale of 11,119,494 shares of Common Stock settled on December 12, 2025 at a net price per share of $18.57. Reflects (i) 13,167,733 shares of Common Stock held directly by GA ALN following the closing of the Transaction and (ii) 135,716 shares of Common Stock and 18,710 restricted stock units held by Nicholas Robbert Vorhoff and 135,716 shares of Common Stock and 18,710 restricted stock units held by David C. Hodgson, in each case for the benefit of General Atlantic Service Company, L.P. ("GASC"). The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3) (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. The Partnership Committee also controls GASC as well as the investment and voting decisions of GAPCO Management. There are six members of the Partnership Committee. Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.
FAQ
What insider transaction in ALHC stock did General Atlantic report?
General Atlantic (ALN HLTH), L.P. reported selling 11,119,494 shares of Alignment Healthcare, Inc. common stock in an open market sale settled on December 12, 2025 at a net price of $18.57 per share.
What is General Atlantics relationship to Alignment Healthcare (ALHC)?
The reporting person is identified as both a Director (by deputization) and a 10% Owner of Alignment Healthcare, Inc. on the Form 4.